retatrutide and type 1 diabetes mechanism triple agonist gip glp-1 glucagon Targeting GLP-1, & GCG in Obesity 2 Research Beyond GLP-1: Retatrutide's triple-agonist mechanism – Retatrutide Provides Substantial Weight Loss

Key finding: Upregulated glycosaminoglycans and proteoglycans essential to wound bed architecture , accelerating extracellular matrix remodeling

Our physicians determine appropriate dosing based on your baseline IGF-1 and treatment goals, and monitor response through regular lab testing

Why Medical Supervision Matters Weight loss medications work best when combined with professional guidance

Compounded semaglutide and the Ivm weight loss program A weekly compounded semaglutide injection that may help you to lose weight, curb hunger, and regulate blood sugar.* Starting at $149/mo Our Commitment: At Ivim Health, we are deeply committed to supporting our patients and empowering our providers to prioritize your health and wellness